Rachel Morgan helps address the biggest challenges faced by CBD manufacturers and suppliers, answering some of the most frequently asked questions.
In this series, Aaron Green sits down and interviews a number of integrated cannabis companies and flower brands. In this Part 5, Green sits down with Bob Fireman, CEO of MariMed, Inc. (OTCQX:MRMD) to learn more about the history of MariMed and its recent equity facility from Hadron Healthcare Fund that has them poised for continued growth.
The cannabis plant is an incredibly versatile plant used in numerous applications: construction materials, textiles, composites, bioplastics, food ingredients, phytochemicals, CBD products, and so much more. Or is that hemp? In this two-part series, Darwin Millard takes the reader down the hemp rabbit hole and discusses how the global market has evolved the definition of hemp over time and the challenges posed by trying to have your cake and eat it too. Millard proposes that we adopt policies for market protection of hemp products through standardization, not bifurcation of the cannabis plant.
In this piece, Khalid Al-Naser makes his case for how Clean Green farming practices with regenerative and sustainable agriculture operations are beneficial for the cannabis industry.
In this piece, Turner describes the applicability of Carbon-14 testing as an option for R&D and quality assurance teams in the CBD industry to measure the percentages of CBD extract in their products that is derived from natural sources. This can be used to authenticate the naturality of products and verify ingredients don’t contain synthetic adulterants.
Green Mill Supercritical recently announced a technology advance that enables winterization onboard the extraction machine during extraction. In this article, Aaron Green interviews Jeff Diehl, Director of Marketing at Green Mill Supercritical, to learn more about the new process.
There has been an explosion of interest in THCV recently, as well as a number of other uncommon cannabinoids. There will be big winners and losers in rare cannabinoid markets, but at the end of the day, the highest quality and lowest cost producers will capture most of these markets.
A Track-n-Trace Nightmare: In this piece, Millard takes the reader step-by-step through a d9-THC remediation process, highlighting the need for a robust track-n-trace program for “hemp extracts.”
In this three-part series, cannabis lawyer and compliance expert Todd Feldman takes a look at how laws shape California’s supply chain, constrains business practices and affects the cost of doing business. In Part Two, we take a look at how regulation defines vertical integration in California.
While the cannabis legalization story in Canada has had its bumps, the clear path forward for greater legal market success lies in increased support for micro-cultivators. By increasing support for these small-scale producers to navigate regulatory requirements, more will be able to enter the legal market and actually compete against their illicit counterparts.
